富蘭克林坦伯頓全球投資系列-新興國家小型企業基金美元I(acc)股
18.55美元0.03(0.16%)
2024/11/11更新
該基金的投資目標是資本增值,透過主要投資於發展中或新興國家成立或其主要業務 在發展中或新興國家的公司及政府所發行的股票證券,及作為輔助性質地投資於償還 債項。該基金亦可投資最高達其資產淨值的 10%於 UCITS 及其他 UCIs 的單位。該基金可合共投資最高達其資產淨值的 20%於中國 A 股及中國 B 股。
大型 | |||
---|---|---|---|
中型 | |||
小型 | |||
價值型 | 均衡型 | 增長型 |
Vikas Chiranewal is a senior executive director with research responsibilities for companies in India and small cap companies across global emerging markets (GEM). In his role as a senior research team member for the GEM/Asia small cap strategy, he is responsible for generating new ideas, coordinating small cap research efforts and leveraging group's resources to add value across funds within the GEM/Asia small cap strategies. Mr. Chiranewal also manages Templeton India Growth Fund and Templeton India Equity Income Fund. Prior to joining Franklin Templeton in 2006, Mr. Chiranewal was a senior associate for Morgan Stanley's equity research team. Before his post-graduate diploma, he worked for McKinsey & Co.'s global research team. Mr. Chiranewal holds a bachelor's degree in commerce from Delhi university and a post graduate diploma in management from the Indian Institute of Management in Lucknow. He is a Chartered Financial Analyst (CFA) charterholder.
Krzysztof Musialik is a senior vice president and senior executive director with research responsibilities for companies in the Pharmaceuticals/Biotechnology sector across global emerging markets. Prior to joining Franklin Templeton in 2006, Mr. Musialik worked for BDO, an audit firm. He entered the financial services industry in 2006. Mr. Musialik graduated in international economics from the Katowice School of Economics and in international business from Toulouse Business School (Ecole Superieure de Commerce de Toulouse). He is a Chartered Financial Analyst (CFA) charterholder and holds an investment advisor license from the Polish Securities and Exchange Commission. Mr. Musialik speaks Polish, English and French.
基金篩選
沒有符合 ”“ 的搜尋結果。